Related Experiment Video
Updated: Jul 13, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
Published on: May 17, 2024
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
1Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-0001, USA. Grosenberg@salud.unm.edu
Abstract:
Cerebral ischemia causes cell swelling and breakdown of the blood-brain barrier (BBB). Cytotoxic edema results from energy failure, and vasogenic edema occurs when the blood vessels are damaged. Proteases and free radicals are the end result of a molecular injury cascade. Matrix metalloproteinases (MMPs) are a gene family of extracellular matrix-degrading enzymes that disrupt the BBB. Tight junction proteins (TJPs), occludin and claudin-5, which form the endothelial barrier, are vulnerable to attack by MMPs. Basal lamina proteins, such as fibronectin, laminin, and heparan sulfate, are also degraded by MMPs. Reperfusion injury leads to a biphasic opening of the BBB, with the early opening occurring several hours after the onset of reperfusion due to activation of the constitutive enzyme gelatinase A (MMP-2). This initial opening is transient and followed 24 to 48 hours later by more intense damage to the blood vessel, which is associated with the expression and activation of gelatinase B (MMP-9) and stromelysin-1 (MMP-3). Synthetic MMP inhibitors restore the early integrity of the BBB but are ineffective in the later opening. Because these inhibitors block MMPs involved in angiogenesis and neurogenesis, they also slow recovery. The challenge is to identify agents that will protect the BBB, blocking vasogenic edema without interfering with recovery.
Insights
Cerebral ischemia damages the blood-brain barrier (BBB) via matrix metalloproteinases (MMPs). While MMP inhibitors initially protect the BBB, they hinder recovery, necessitating new therapeutic strategies.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Cerebral ischemia induces cell swelling and blood-brain barrier (BBB) disruption.
- Vasogenic edema arises from blood vessel damage, distinct from cytotoxic edema due to energy failure.
- Matrix metalloproteinases (MMPs) are key enzymes that degrade extracellular matrix and compromise BBB integrity.
Purpose of the Study:
- To investigate the role of MMPs in BBB breakdown during cerebral ischemia and reperfusion.
- To evaluate the efficacy of MMP inhibitors in protecting the BBB.
- To identify therapeutic targets for preventing vasogenic edema without impeding neurological recovery.
Main Methods:
- Analysis of MMP activation and activity following cerebral ischemia.
- Assessment of BBB integrity, including tight junction proteins and basal lamina components.
- Evaluation of the effects of synthetic MMP inhibitors on BBB opening and recovery processes.
Main Results:
- MMPs, particularly MMP-2, MMP-9, and MMP-3, are implicated in the biphasic opening of the BBB after reperfusion.
- Synthetic MMP inhibitors can restore early BBB integrity but are ineffective against later, more severe damage.
- These inhibitors also impede angiogenesis and neurogenesis, thereby slowing functional recovery.
Conclusions:
- The biphasic opening of the BBB involves distinct MMPs at different time points post-reperfusion.
- Current MMP inhibitors offer incomplete protection and can hinder recovery.
- Developing agents that selectively target pathological BBB opening while preserving repair mechanisms is crucial for treating cerebral ischemia.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction
Cytotoxic Edema: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology

